Form 8-K · Current report
Zoetis 8-K, filed Aug 6, 2026
- Filed
- CIK
- 0001555280
- Accession no.
- 0001555280-26-000038
Summary
Zoetis reported flat second-quarter 2026 revenue of $2.5 billion and net income of $691 million, or $1.65 per diluted share, and revised its full-year 2026 guidance down to $9.120–$9.320 billion in revenue and $6.15–$6.25 in adjusted diluted EPS. CEO Kristin Peck attributed the pressure to lower clinic visits, pet-owner price sensitivity, and heightened competition in companion animal categories, while citing strength in livestock and diagnostics.
Key points
- Second-quarter 2026 revenue was $2.5 billion, flat year over year and down 1% on an organic operational basis; adjusted net income was $781 million, or $1.87 per diluted share.
- U.S. segment revenue fell 7% to $1.3 billion, with companion animal sales down 11%, while International segment revenue rose 8% to $1.2 billion.
- Zoetis completed the acquisition of VitalRADS, a veterinary teleradiology platform, in July 2026.
- Full-year 2026 guidance was revised to reported net income of $2.330–$2.380 billion and adjusted net income of $2.570–$2.620 billion, reflecting foreign exchange rates as of July 21, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On August 6, 2026, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2026 and its guidance for full year 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.